James V. Caruso

James V. Caruso

Chief Executive Officer at CELLECTAR BIOSCIENCES, INC.

Net worth: 148 641 $ as of 2024-04-29

65 year
Health Technology
Consumer Services

Network origin in James V. Caruso first degree

EntityEntity typeIndustry
Public Company Pharmaceuticals: Major 24
18
Subsidiary Pharmaceuticals: Major 18
Knoll Pharmaceutical Co.
7
Subsidiary 7
5
Extinct Pharmaceuticals: Other 5
Hip Innovation Technology LLC
4
Private Company 4
3
Subsidiary Pharmaceuticals: Major 3
3
Subsidiary Pharmaceuticals: Major 3

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to James V. Caruso via their personal network

CompanySectorRelated peopleMain position
ABBOTT LABORATORIES Medical Specialties

Luke Seikkula

Paul Berns

Stefan Loren

Kenneth Kashkin

Robert Stewart

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

University of Wisconsin College/University

John Neis

Paul Berns

Jamey P. Weichert

John Patrick Genn

Graduate Degree

Undergraduate Degree

Corporate Officer/Principal

Undergraduate Degree

Biotechnology

Simon Pedder

Elizabeth Czerepak

Robert Stewart

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Corporate Officer/Principal

LA JOLLA PHARMACEUTICAL COMPANY Pharmaceuticals: Major

Bruce K. Bennett

Luke Seikkula

William Ringo

Corporate Officer/Principal

Chief Operating Officer

Director/Board Member

SPECTRUM PHARMACEUTICALS, INC. Pharmaceuticals: Major

Luke Seikkula

Elizabeth Czerepak

Steven Fruchtman

Corporate Officer/Principal

Director/Board Member

Chief Tech/Sci/R&D Officer

College/University

Jeffrey R. Latts

Jamey P. Weichert

Doctorate Degree

Undergraduate Degree

Icahn School of Medicine at Mount Sinai College/University

Melvin Spigelman

Steven Fruchtman

Doctorate Degree

Corporate Officer/Principal

ONCOTELIC THERAPEUTICS, INC. Biotechnology

Fred Driscoll

Simon Pedder

Chief Executive Officer

Director/Board Member

CHELSEA THERAPEUTICS INTERNATIONAL LTD. Biotechnology

Simon Pedder

Kathryn M. McNeil

Founder

Investor Relations Contact

Pharmaceuticals: Major

Charles Thomas Bernhardt

Charles Q. Morris

Corporate Officer/Principal

Corporate Officer/Principal

THE MEDICINES COMPANY Pharmaceuticals: Major

Melvin Spigelman

Douglas Kling

Director/Board Member

Corporate Officer/Principal

PFIZER, INC. Pharmaceuticals: Major

William Ringo

Kevin Sidow

Corporate Officer/Principal

Corporate Officer/Principal

Villanova University College/University

Charles Thomas Bernhardt

Michael E. Schick

Undergraduate Degree

Undergraduate Degree

DELCATH SYSTEMS, INC. Medical Specialties

Simon Pedder

Elizabeth Czerepak

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Stewart John Hen

Nishan de Silva

Director/Board Member

Director/Board Member

MERCK & CO., INC. Pharmaceuticals: Major

Stewart John Hen

Jeffrey A. Peris

Corporate Officer/Principal

Human Resources Officer

Pharmaceuticals: Major

Pablo Cagnoni

William Ringo

President

Director/Board Member

University of Pennsylvania College/University

Stewart John Hen

Bruce Goldsmith

Masters Business Admin

Doctorate Degree

Investment Managers

Stewart John Hen

Nishan de Silva

Private Equity Investor

Private Equity Investor

Pharmaceuticals: Major

Jarrod Longcor

Laurence Reilly

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Fairleigh Dickinson University College/University

Gary D. Dolch

Robert Stewart

Graduate Degree

Director/Board Member

Pharmaceuticals: Major

David Stout

William Ringo

President

Sales & Marketing

Pharmaceuticals: Major

Robert E. Pelzer

Steven Fruchtman

General Counsel

Corporate Officer/Principal

Pharmaceuticals: Major

Gary D. Dolch

Jeffrey A. Peris

Corporate Officer/Principal

Human Resources Officer

JOHNSON & JOHNSON Pharmaceuticals: Major

John Hamill

Bruce Goldsmith

Corporate Officer/Principal

Corporate Officer/Principal

RADIUS HEALTH, INC. Biotechnology

Elizabeth Czerepak

Charles Q. Morris

Director/Board Member

Chief Tech/Sci/R&D Officer

ELI LILLY AND COMPANY Pharmaceuticals: Major

William Ringo

Thorlef Spickschen

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Paul Berns

Thorlef Spickschen

Sales & Marketing

Chief Executive Officer

LIGAND PHARMACEUTICALS INCORPORATED Pharmaceuticals: Major

Nishan de Silva

Sunil Patel

Director of Finance/CFO

Director/Board Member

University of California, Berkeley College/University

Stefan Loren

Sunil Patel

Doctorate Degree

Undergraduate Degree

Medical Specialties

John Neis

Chad J. Kolean

Director/Board Member

Comptroller/Controller/Auditor

Boston University College/University

Douglas Swirsky

Arun Nadiga

Undergraduate Degree

Undergraduate Degree

GENVEC INC Pharmaceuticals: Major

Douglas Swirsky

Stefan Loren

Chief Executive Officer

Director/Board Member

POLYMEDIX, INC. Pharmaceuticals: Major

Douglas Swirsky

Stefan Loren

Director/Board Member

Director/Board Member

MAXCYTE, INC. Biotechnology

Douglas Swirsky

Jarrod Longcor

Director of Finance/CFO

Corporate Officer/Principal

Miscellaneous Commercial Services

Nishan de Silva

Sunil Patel

Corporate Officer/Principal

Corporate Officer/Principal

LEGG MASON, INC. Investment Managers

Douglas Swirsky

Stefan Loren

Corporate Officer/Principal

Private Equity Investor

Medical Specialties

Kevin Sidow

Director/Board Member

Medical Specialties

Kevin Sidow

Director/Board Member

Medical Specialties

Kevin Sidow

Director/Board Member

Investment Managers

Nishan de Silva

Corporate Officer/Principal

Miscellaneous Commercial Services

Kevin Sidow

Director/Board Member

Yale University College/University

Kenneth Kashkin

Corporate Officer/Principal

Statistics

International

United States 48
United Kingdom 2
Germany 2
Israel 2

Sectoral

Health Technology 36
Consumer Services 10
Commercial Services 4
Finance 4

Operational

Director/Board Member 239
Corporate Officer/Principal 148
Independent Dir/Board Member 72
Director of Finance/CFO 59
Chief Executive Officer 52
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW